| Titre : | LE TRAITEMENT NEUROCHIRURGICAL DE L'EPILEPSIE TEMPORALE PHARMACO-RESISTANTE | | Type de document : | thèse | | Auteurs : | BENHMIDA KAWTAR, Auteur | | Année de publication : | 2022 | | Langues : | Anglais (eng) | | Mots-clés : | Refractory epilepsy temporal lobe epilepsy surgery prognosis Engel Refractory epilepsy Temporal lobe epilepsy Surgery Prognosis Engel لا مواقملا ة9ودلأل ع,لا 0دصلا ةحارجلا نهكتلا ف?Kصت لجنإ . | | Résumé : | The aim of our study is to analyze the impact of refractory epilepsy surgery on the prognosis of
epilepsy in TLE patients of a series of 100 patients who underwent surgery at department the “Hôpital
des Spécialités- Rabat “over a period of 15 years (2005-2020).
The mean age at surgery is 26.3 years. The most affected age group is that between 20 and 29
with no significant predominance (F:51/M:49). The mean age at onset of epilepsy was 11,6 years and
the median duration of epilepsy at the time of the surgery was 14,6 years.
Type of epilepsy was focal in 24% combined (F+G) in 27% and generalized in 23%. 65.9%
presented an automatism. The seizure frequency was weekly in 39.8%. The patients were treated with
2.34 ± 0.837 AEDs.
Presurgical assessment revealed:
• Video EEG finding were focal in 91.6%. PET scan: hypometabolism in 2 patients.
• MRI: SH (48%), DNET (19%), Glioma (9%), FCD (6%), undefined lesional abnormalities
(15%), cavernoma (3%).
The surgery type was TL in 88% (L:45; R:43) and lesionectomy in 12%(L:5 ; R:7).
The histopathologic examination revealed: HS (40%), DNET (21%), oligodendroglioma (13%),
dysplasia (7%), cavernoma (3%) and (1%) astrocytoma.
The rate of minor complication was 25 % and the rate of post-operative mortality was zero.
Engel’s classification at the last follow up (2-11 years) was favourable in 80% (Engel I). Only
one patient was Engel IV (DNET) and died from a SUDEP one year post surgery.
A significant reduction in AEDs was noticed from (2.34 ± 0.837 SD AEDs) before the surgery to
(1.93 ± 0.959 SD; p: 0.029), 7.3% were free from AED at the last follow up.
The results of our study are encouraging despite the use of only non-invasive methods. Surgery
remains better than prolonged medical treatment in adult patients with drug refractory temporal lobe
epilepsy.
| | Numéro (Thèse ou Mémoire) : | M0692022 | | Président : | Abdessamad El OUAHABI | | Directeur : | Abdessamad El OUAHABI | | Juge : | Mohamed JIDDANE | | Juge : | Miloudi GAZZAZ | | Juge : | Nazha BIROUK ; Adyl MELHAOUI |
LE TRAITEMENT NEUROCHIRURGICAL DE L'EPILEPSIE TEMPORALE PHARMACO-RESISTANTE [thèse] / BENHMIDA KAWTAR, Auteur . - 2022. Langues : Anglais ( eng) | Mots-clés : | Refractory epilepsy temporal lobe epilepsy surgery prognosis Engel Refractory epilepsy Temporal lobe epilepsy Surgery Prognosis Engel لا مواقملا ة9ودلأل ع,لا 0دصلا ةحارجلا نهكتلا ف?Kصت لجنإ . | | Résumé : | The aim of our study is to analyze the impact of refractory epilepsy surgery on the prognosis of
epilepsy in TLE patients of a series of 100 patients who underwent surgery at department the “Hôpital
des Spécialités- Rabat “over a period of 15 years (2005-2020).
The mean age at surgery is 26.3 years. The most affected age group is that between 20 and 29
with no significant predominance (F:51/M:49). The mean age at onset of epilepsy was 11,6 years and
the median duration of epilepsy at the time of the surgery was 14,6 years.
Type of epilepsy was focal in 24% combined (F+G) in 27% and generalized in 23%. 65.9%
presented an automatism. The seizure frequency was weekly in 39.8%. The patients were treated with
2.34 ± 0.837 AEDs.
Presurgical assessment revealed:
• Video EEG finding were focal in 91.6%. PET scan: hypometabolism in 2 patients.
• MRI: SH (48%), DNET (19%), Glioma (9%), FCD (6%), undefined lesional abnormalities
(15%), cavernoma (3%).
The surgery type was TL in 88% (L:45; R:43) and lesionectomy in 12%(L:5 ; R:7).
The histopathologic examination revealed: HS (40%), DNET (21%), oligodendroglioma (13%),
dysplasia (7%), cavernoma (3%) and (1%) astrocytoma.
The rate of minor complication was 25 % and the rate of post-operative mortality was zero.
Engel’s classification at the last follow up (2-11 years) was favourable in 80% (Engel I). Only
one patient was Engel IV (DNET) and died from a SUDEP one year post surgery.
A significant reduction in AEDs was noticed from (2.34 ± 0.837 SD AEDs) before the surgery to
(1.93 ± 0.959 SD; p: 0.029), 7.3% were free from AED at the last follow up.
The results of our study are encouraging despite the use of only non-invasive methods. Surgery
remains better than prolonged medical treatment in adult patients with drug refractory temporal lobe
epilepsy.
| | Numéro (Thèse ou Mémoire) : | M0692022 | | Président : | Abdessamad El OUAHABI | | Directeur : | Abdessamad El OUAHABI | | Juge : | Mohamed JIDDANE | | Juge : | Miloudi GAZZAZ | | Juge : | Nazha BIROUK ; Adyl MELHAOUI |
|
Accueil
Affiner la recherche Faire une suggestionLE TRAITEMENT NEUROCHIRURGICAL DE L'EPILEPSIE TEMPORALE PHARMACO-RESISTANTE / BENHMIDA KAWTAR
